Abdera Therapeutics

Abdera Therapeutics company information, Employees & Contact Information

Abdera Therapeutics Inc. is a precision oncology company developing next-generation targeted radiation therapies - one of the most cutting-edge and highly promising areas of drug development. The company is built on a proprietary modular technology platform optimized for the delivery of radioisotopes to selectively destroy tumor cells while sparing healthy cells. Abdera is using this platform to enable the rapid development of a broad range of safe and efficacious therapies serving cancer patients with limited treatment options. Abdera Therapeutics is growing rapidly and seeking key new team members who thrive at the cutting-edge of innovation. Come join us and be a part of the ground-breaking team set to unlock the power of targeted radiotherapy!

Company Details

Employees
79
Address
901 Gateway Blvd, South San Francisco,california 94080,united States
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
HQ
South San Francisco, California
Looking for a particular Abdera Therapeutics employee's phone or email?

Abdera Therapeutics Questions

News

Abdera Therapeutics Appoints Rachael Brake, Ph.D., as Chief Scientific Officer - Yahoo Finance

Abdera Therapeutics Appoints Rachael Brake, Ph.D., as Chief Scientific Officer Yahoo Finance

FDA Grants Fast Track Designation to ABD-147 for ES-SCLC - OncLive

FDA Grants Fast Track Designation to ABD-147 for ES-SCLC OncLive

Abdera Therapeutics Expands Management Team and Board of Directors - Business Wire

Abdera Therapeutics Expands Management Team and Board of Directors Business Wire

FDA Awards Orphan Drug Designation to ABD-147 for Neuroendocrine Carcinoma - OncLive

FDA Awards Orphan Drug Designation to ABD-147 for Neuroendocrine Carcinoma OncLive

Abdera Therapeutics Debuts With $142 Million in Financing to Engineer and Advance Best-in-Class Antibody-Based Radiopharmaceuticals for Cancer - Business Wire

Abdera Therapeutics Debuts With $142 Million in Financing to Engineer and Advance Best-in-Class Antibody-Based Radiopharmaceuticals for Cancer Business Wire

Top Abdera Therapeutics Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant